|
SMG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.32605079431414E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.39985850373159E-12 |
| Normal-vs-Stage2 |
3.7917446960023E-12 |
| Normal-vs-Stage3 |
1.78945747109083E-12 |
| Normal-vs-Stage4 |
1.63991042967382E-12 |
| Stage1-vs-Stage2 |
3.188600E-01 |
| Stage1-vs-Stage3 |
8.221500E-02 |
| Stage1-vs-Stage4 |
6.938700E-03 |
| Stage2-vs-Stage3 |
7.698400E-01 |
| Stage2-vs-Stage4 |
2.448400E-01 |
| Stage3-vs-Stage4 |
3.309200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.84674539286334E-13 |
| Normal-vs-AfricanAmerican |
6.9769999999636E-07 |
| Normal-vs-Asian |
6.22599971578097E-10 |
| Caucasian-vs-AfricanAmerican |
5.952000E-01 |
| Caucasian-vs-Asian |
4.625000E-01 |
| AfricanAmerican-vs-Asian |
9.853800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.5024426975051E-13 |
| Normal-vs-Female |
2.81774603649865E-12 |
| Male-vs-Female |
3.706000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.58499888161623E-11 |
| Normal-vs-Age(41-60Yrs) |
4.46420678201775E-13 |
| Normal-vs-Age(61-80Yrs) |
3.14193115968919E-14 |
| Normal-vs-Age(81-100Yrs) |
8.3515000000034E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.061160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.197870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.573800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.427600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.342600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.374200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.412200E-02 |
| Classical-VS-Follicular |
4.687900E-02 |
| Classical-VS-Other |
5.373000E-01 |
| Classical-VS-Normal |
3.78720388383158E-11 |
| Tall-VS-Follicular |
6.087600E-01 |
| Tall-VS-Other |
7.074800E-01 |
| Tall-VS-Normal |
4.42779146681005E-12 |
| Follicular-VS-Other |
9.569400E-01 |
| Follicular-VS-Normal |
1.3425927036792E-12 |
| Other-VS-Normal |
1.037390E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02993177822464E-12 |
| Normal-vs-N1 |
8.67306226837172E-12 |
| N0-vs-N1 |
7.888600E-01 |
|
|
